Reflect on the provided data and tweets to anticipate if the closing price of $bmy is going to increase or decrease at 2017-08-02. Kindly respond with either Rise or Fall.
Context: date,open,high,low,close,adj-close,inc-5,inc-10,inc-15,inc-20,inc-25,inc-30
2017-07-19,-0.5,0.2,-0.8,0.6,0.6,-0.3,0.2,0.5,0.9,0.5,-0.2
2017-07-20,-0.3,0.5,-0.5,0.7,0.7,-0.7,-0.4,-0.2,0.2,-0.1,-0.6
2017-07-21,-0.4,0.2,-0.5,0.4,0.4,-0.9,-0.8,-0.5,-0.3,-0.3,-0.8
2017-07-24,0.1,0.6,-0.8,-0.1,-0.1,-0.5,-0.8,-0.4,-0.3,-0.1,-0.6
2017-07-25,-0.2,0.4,-0.3,0.6,0.6,-0.7,-1.3,-1.0,-0.9,-0.7,-1.1
2017-07-26,-0.1,0.3,-0.9,0.1,0.1,-0.5,-1.2,-1.1,-0.9,-0.7,-1.0
2017-07-27,-1.7,0.4,-4.0,-3.1,-3.1,2.3,1.9,2.0,2.1,2.4,2.2
2017-07-28,-1.9,0.6,-2.4,1.9,1.9,0.3,0.0,-0.0,0.2,0.4,0.3
2017-07-31,-2.3,0.5,-2.5,2.9,3.0,-2.2,-2.5,-2.8,-2.5,-2.5,-2.4
2017-08-01,1.9,1.9,-0.8,-1.4,-1.4,-0.7,-0.9,-1.3,-1.1,-1.1,-0.9

2017-07-19: tower bridge advisors reduces position in bristol-myers squibb company $bmy |rt AT_USER leerink's fernandez says $mrk's keytruda's gains against $bmy's opdivo are accelerating |#cboscore $spy $ci $hum
2017-07-20: rt AT_USER $bmy flagging &gt;200dma |rt AT_USER $bmy flagging &gt;200dma |$bmy flagging &gt;200dma |$bmy is in ema33 breakout winning 63.01% in the past.  |q2 2017 eps estimates for bristol-myers squi
2017-07-21: rt AT_USER bristol myers $bmy with 5k aug. 4th (w) $60 calls bought, earlier this week 5k each of the $56 and $57 calls opened|rt AT_USER next week is going to be fun. $gild is wednesday and then both
2017-07-22: #biotech exec, with #cancer, on new drug expectations   #immunotherapy #cancerresearch¡­ |little upside for bristol-myers squibb company $bmy investors prior to earnings next thursday¡­ |rt AT_USER go
2017-07-23: bmy early trade bull, about to breakout $bmy |some names with er this week $hal $has $goog $aks $gm $stx $mcd $cat $fcx $jblu $mmm $biib $lly $exas $dd $f $ba $ko $twtr $clf $bmy $ma|rt AT_USER 3 thin
2017-07-24: rt AT_USER fda accepts $bmy's applications for opdivo 4-week dosing schedule across all approved indications. |s&amp;p100 #stocks performance $gd $amgn $msft $nee $rtn $bmy $celg $cat $fdx $jnj $pcln 
2017-07-25: #bristolmyerssquibb how bristol could put the hurt on dow's merck in immuno-oncology. read more:  $bmy|#bristolmyerssquibb fda accepts bristol-myers squibb???s applications for opdivo (nivolumab)... r
2017-07-26: rt AT_USER join us tomorrow at 10:30am edt for our q2 earnings call &amp; follow us here for live tweets. learn more: |commented on gilead puts up the good fight once again  $bmy $gsk $pfe $gild|rt AT
2017-07-27: $bmy declines -3.1% on q2 earnings vs an expected ¡à3.5% move according to the 28-jul-17 options straddle |#bristolmyerssquibb astrazeneca cancer drug failure doesn't bode well for bristol myers. read
2017-07-28: investors sell shares of bristol-myers squibb company $bmy on strength $bmy |traders sell shares of bristol-myers squibb company $bmy on strength $bmy |traders sell shares of bristol-myers squibb comp
2017-07-29: downgrades  $actg $adnt $amed $amzn $atr $bbw $bc $bjri $bms $bmy $boja $byd $cag $cash $cdtx $cmcsa $cmpr $colb|bristol-myers squibb company $bmy shares sold by louisiana state employees retirement s
2017-07-30: main street research llc has $1.89 million position in bristol-myers squibb company $bmy |main street research llc has $1.89 million position in bristol-myers squibb company $bmy |wendell david associ
2017-07-31: $clvs jpm takeover thesis not off the table, $bmy collab no strings attached no financial terms, no first right refusal if interested party|rt AT_USER jpmorgan says clovis and bristol-myers collaborat
2017-08-01: 3 things in biotech you should learn today: august 2, 2017  $amgn $azn $bmy $clvs $mrk $tsro|rt seekingalpha "3 things in biotech you should learn today: august 2, 2017  $amgn $azn $bmy $clvs $mrk $ts
Answer:
Fall